IMO, a positive outcome from the comments made in these two paragraphs alone would see s/p skyrocket. Just hope there are no lurking vultures keeping the s/p artifically low. Last thing we want is a hostile takeover.
"Therapeutic midkine antibody program
Therapeutic antibodies continue to be the fastest growing area of drug development and can potentially provide a highly lucrative investment even in an early stage. Several preclinical stage deals have been done over the years, most recently an option and licensing deal between Celgene and Inhibrx valued at $500 million including
upfront, milestone and royalty payments."
"Midkine as early diagnostic and prognostic marker for cancer
Over the past year several diagnostic and pharma companies have expressed interest in midkine as an early cancer diagnostic marker. The Company’s strategy has previously been limited to out-licensing midkine on an indication
basis for the early diagnosis of cancer. In early 2012 we added strong prognostic data to our licensing package and we are currently talking to a dozen groups, mostly as to the utility of midkine as a prognostic agent."
- Forums
- ASX - By Stock
- AN1
- newsletter
newsletter
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.229M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1197315 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 109888 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1197315 | 0.007 |
5 | 865639 | 0.006 |
1 | 300000 | 0.005 |
3 | 825000 | 0.004 |
1 | 600000 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 109888 | 2 |
0.009 | 280000 | 1 |
0.010 | 157763 | 1 |
0.012 | 4000 | 1 |
0.013 | 750000 | 1 |
Last trade - 16.12pm 16/08/2024 (20 minute delay) ? |
Featured News
AN1 (ASX) Chart |
Day chart unavailable